Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2010
05/13/2010US20100120755 Conjugated psychotropic drugs and uses thereof
05/13/2010US20100120754 Identification and use of small molecules to modulate transcription factor function and to treat transcription factor associated diseases
05/13/2010US20100120753 Anti-Infective Agents
05/13/2010US20100120752 Muscarinic agonists to treat impulse control disorders
05/13/2010US20100120751 Spiro-5,6-dihydro-4h-2,3,5,10b-tetraaza-benzo[e]azulenes
05/13/2010US20100120750 Methods for inducing polyploidization of megakaryocytes and for treating blood and bone marrow diseases and disorders
05/13/2010US20100120749 Tetrahydroindole derivatives as nadph oxidase inhibitors
05/13/2010US20100120748 Benzoazepin-oxy-acetic acid derivatives as ppar-delta agonists used for the increase of hdl-c, lower ldl-c and lower cholesterol
05/13/2010US20100120747 Combination of a cholinesterase inhibitor and a compound with 5-ht6 receptor affinity
05/13/2010US20100120746 Use of r-10-hydroxy-10,11-dihydro-carbamazepine in neuropathic pain
05/13/2010US20100120745 Anti-angiogenic agents and methods of use
05/13/2010US20100120744 Acetamidopropane modulators of nmda receptors
05/13/2010US20100120743 11Beta-Hydroxysteroid Dehydrogenase Type 1 Active Compounds
05/13/2010US20100120742 Rexinoid compound having alkoxy group
05/13/2010US20100120741 Heterocyclic inhibitors of histamine receptors for the treatment of disease
05/13/2010US20100120740 Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
05/13/2010US20100120739 Triazolopyridazine protein kinase modulators
05/13/2010US20100120738 Anti-apoptotic benzodiazepine receptor ligand inhibitors
05/13/2010US20100120737 Amorphous ciclesonide
05/13/2010US20100120736 Mineralocorticoid Receptor Antagonists
05/13/2010US20100120735 Compound showing anti-inflammatory activity and antiviral activity, pharmaceutical compositions comprising the same, a process for obtaining the same and use of the same in the treatment of epidemic keratoconjunctivites and herpetic stromal keratis
05/13/2010US20100120734 Formoterol/steroid bronchodilating compositions and methods of use thereof
05/13/2010US20100120733 Steroid modulators of glucocorticoid receptor
05/13/2010US20100120732 Agent for prevention and/or treatment of systemic lupus erythematosus
05/13/2010US20100120731 3-([1,2,4]triazolo [4,3-a]pyridin-7-yl)benzamide derivatives
05/13/2010US20100120730 6-benzyl-2,3,4,7-tetrahydro-indolo [2,3-c] quinoline compounds useful as pde5 inhibitors
05/13/2010US20100120729 Pheromone-containing cosmetic agents
05/13/2010US20100120728 Method of Treating Vitamin D Insufficiency and Deficiency
05/13/2010US20100120727 Eflornithine Prodrugs, Conjugates and Salts, and Methods of Use Thereof
05/13/2010US20100120726 1-Methylnicotinamide Derivatives and Formulations of Treatment of Lipoprotein Abnormalities
05/13/2010US20100120725 Substituted Phenylsulfonamide Inhibitors of Beta Amyloid Production
05/13/2010US20100120723 Pharmaceutical composition comprising a hot-melt granulated lubricant
05/13/2010US20100120722 Heterocyclic compounds for preventing and treating disorders associated with excessive bone loss
05/13/2010US20100120721 Substituted piperidinophenyl oxazolidinones
05/13/2010US20100120720 Use of hmg-coa reductase and farnesyl-pyrophosphate synthase inhibitors for the preparation of a medicine
05/13/2010US20100120719 Lyophilization formulation
05/13/2010US20100120718 Combination therapy of substituted oxazolidinones
05/13/2010US20100120717 Kinase inhibitors
05/13/2010US20100120716 Macrocyclic hepatitis c serine protease inhibitors and uses therefor
05/13/2010US20100120715 Beta-lactamase inhibitors
05/13/2010US20100120713 Compositions containing beta-carotene
05/13/2010US20100120712 Pharmaceutical composition for meniere's disease
05/13/2010US20100120711 Ampk potentiator containing chito-oligosaccharide
05/13/2010US20100120710 Branched alpha-glucan, alpha-glucosyltransferase which forms the glucan, their preparation and uses
05/13/2010US20100120709 Cytidine derivative-containing antitumor agent for continuous intravenous administration
05/13/2010US20100120708 Combination therapy comprising ZD6474 and gemcitabine for anti-cancer therapy
05/13/2010US20100120707 Dosages for menstrual suppression, contraception, and hormone replacement therapy, and methods of administering same
05/13/2010US20100120706 Macrolides Useful Against Inflammatory and Allergic Diseases
05/13/2010US20100120705 Compositions and products containing s-equol, and methods for their making
05/13/2010US20100120704 Cardiac glycosides to treat cystic fibrosis and other IL-8 dependent disorders
05/13/2010US20100120703 Compositions and methods for treating cancer
05/13/2010US20100120702 Solid preparation for dialysis
05/13/2010US20100120701 Compositions and Methods For Engineering Probiotic Yeast
05/13/2010US20100120688 ErbB Interface Peptidomimetics And Methods Of Use Thereof
05/13/2010US20100120685 Methods and compositions for the treatment of cancer
05/13/2010US20100120679 Targeting NBS1-ATM Interaction To Sensitize Cancer Cells To Radiotherapy And Chemotherapy
05/13/2010US20100120669 Thiadiazole derivatives, inhibitors of stearoyl-coa desaturase
05/13/2010US20100120665 Treatment of diseases characterized by inflammation
05/13/2010US20100120662 Glucose uptake modulator and method for treating diabetes or diabetic complications
05/13/2010US20100120661 Heterocyclic boronic acid compounds
05/13/2010US20100120652 Treatment of bed mite and bed bug infestations
05/13/2010US20100119694 Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
05/13/2010US20100119630 Valerian extract preparation
05/13/2010US20100119626 Genetic Markers for Assessing Risk of Developing Schizophrenia
05/13/2010US20100119625 Genetic Markers of Schizophrenia Endophenotypes
05/13/2010US20100119624 Benzisoxazole modulators of d2 receptor and/or 5-ht2a receptor
05/13/2010US20100119623 Imidazolyl modulators of 5-ht3 receptors
05/13/2010US20100119622 3h-benzooxazol-2-one modulators of d2 receptor and/or 5-ht1a receptor
05/13/2010US20100119621 Process for preparing oral calcium compositions
05/13/2010US20100119613 Process to activate extracts derived from living organisms using long wave uv irradiation and compositions comprising said activated extract
05/13/2010US20100119612 Nanoparticles comprising non-crystalline drug
05/13/2010US20100119611 Delivery of a Bioactive Material
05/13/2010US20100119610 Packaged pegylated gold nanoparticles
05/13/2010US20100119609 Methods, compositions, and formulations for the treatment of thyroid eye disease
05/13/2010US20100119608 Synthesis of pH-sensitive, Acid-Stable Metal-Binding Nanoparticles
05/13/2010US20100119607 Bioenhanced compositions
05/13/2010US20100119606 Processes and apparatus for extraction of active substances and enriched extracts from natural products
05/13/2010US20100119605 Compositions for tissue stabilization
05/13/2010US20100119603 Nanoparticles comprising a drug,ethycellulose,and a bile salt
05/13/2010US20100119601 Melatonin tablet and methods of preparation and use
05/13/2010US20100119600 Substances for reducing occurrence of major cardiac events comprising red yeast rice extract and omega-3 polyunsaturated fatty acid or derivative thereof
05/13/2010US20100119599 Polyhydroquinoline compounds and dihydropyridine compounds for inhibiting beta-amyloid production
05/13/2010US20100119598 Seamless capsule
05/13/2010US20100119596 Formulations of suberoylanilide hydroxamic acid and methods for producing same
05/13/2010US20100119595 Monounsaturated fatty acids and perhydrocyclopentanophenanthrene nucleus combination molecules, and their precursors, and the use of all of these as weight-loss agents
05/13/2010US20100119594 Nourin and nourin antagonists
05/13/2010US20100119593 Liposome and method for producing the same
05/13/2010US20100119592 Cytarabine for treatment of glioma
05/13/2010US20100119591 Use of lipid containing particles comprising quillaja saponins for the treatment of cancer
05/13/2010US20100119590 Method of drug loading in liposomes by gradient
05/13/2010US20100119589 Liposomal composition of antioxidants for inhalations carried out during lung and upper respiratory tract diseases
05/13/2010US20100119587 Solid lipidic particles as pharmaceutically acceptable fillers or carriers for inhalation
05/13/2010US20100119585 Transdermal therapeutic system for administering the active substance buprenorphine
05/13/2010US20100119584 Medicated patch comprising 5-methyl-1-phenyl-2-(1h)-pyridone
05/13/2010US20100119581 Medical Products That Release Pharmaceutically Active Substances
05/13/2010US20100119580 Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
05/13/2010US20100119578 Extracellular matrix modulating coatings for medical devices
05/13/2010US20100119570 Solid Pharmaceutical And Vaccine Dose
05/13/2010US20100119561 Compositions Having a Performance Indicator
05/13/2010US20100119560 Nano-emulsion, the use thereof, and preparation method thereof
1 ... 2270 2271 2272 2273 2274 2275 2276 2277 2278 2279 2280 2281 2282 2283 2284 2285 2286 2287 2288 2289 2290 ... 7860